Andra AP fonden Lowers Holdings in Tenet Healthcare Corporation $THC

Andra AP fonden decreased its position in Tenet Healthcare Corporation (NYSE:THC) by 90.5% during the third quarter, HoldingsChannel.com reports. The firm owned 1,600 shares of the company’s stock after selling 15,199 shares during the quarter. Andra AP fonden’s holdings in Tenet Healthcare were worth $325,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Crestwood Advisors Group LLC boosted its stake in Tenet Healthcare by 2.5% during the 3rd quarter. Crestwood Advisors Group LLC now owns 2,606 shares of the company’s stock valued at $529,000 after purchasing an additional 64 shares during the last quarter. ProShare Advisors LLC lifted its holdings in shares of Tenet Healthcare by 1.7% during the second quarter. ProShare Advisors LLC now owns 4,118 shares of the company’s stock valued at $725,000 after purchasing an additional 67 shares in the last quarter. Quadcap Wealth Management LLC increased its holdings in Tenet Healthcare by 1.7% in the 2nd quarter. Quadcap Wealth Management LLC now owns 4,099 shares of the company’s stock worth $721,000 after buying an additional 69 shares in the last quarter. Andina Capital Management LLC raised its position in Tenet Healthcare by 2.1% in the 3rd quarter. Andina Capital Management LLC now owns 3,360 shares of the company’s stock worth $682,000 after buying an additional 69 shares during the last quarter. Finally, Choreo LLC boosted its holdings in shares of Tenet Healthcare by 2.9% during the 3rd quarter. Choreo LLC now owns 2,636 shares of the company’s stock valued at $535,000 after acquiring an additional 75 shares during the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

THC has been the topic of several research reports. Wells Fargo & Company restated an “overweight” rating and issued a $265.00 target price on shares of Tenet Healthcare in a report on Monday, February 16th. JPMorgan Chase & Co. raised their price target on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Barclays increased their target price on Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a report on Friday, February 13th. UBS Group boosted their price target on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Finally, Leerink Partners raised their price objective on shares of Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a report on Friday, February 20th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $247.67.

Insider Activity

In other news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Performance

NYSE THC opened at $238.68 on Monday. The stock has a market capitalization of $20.76 billion, a PE ratio of 15.41, a P/E/G ratio of 1.18 and a beta of 1.39. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $240.83. The business has a 50 day simple moving average of $206.02 and a two-hundred day simple moving average of $200.15. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business’s quarterly revenue was up 8.9% on a year-over-year basis. During the same period in the previous year, the firm posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, research analysts predict that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Wall Street Zen upgraded THC to a “Strong‑Buy,” signaling fresh buy-side interest and likely supporting demand for the stock. Article Title
• Positive Sentiment: Zacks and other outlets have raised near‑term earnings estimates (Q1/Q2 FY2026 and FY2026), which supports the company’s earnings trajectory and provides backing for current valuation assumptions. Article Title
• Neutral Sentiment: A Yahoo Finance piece questions whether it’s too late to buy after an ~89% one‑year rally — this is market commentary on valuation and investor sentiment rather than new company fundamentals, and can amplify volatility as investors reassess upside. Article Title
• Negative Sentiment: Zacks’ detailed notes are mixed: while they raised FY2026 and some near‑term quarter forecasts, they trimmed several FY2027 and late‑year quarterly estimates (Q3/Q4 2027 and FY2027), indicating analyst caution about longer‑term growth and limiting upward re‑rating potential. Article Title

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.